TY  - GEN
AU  - Nakayama,Hideki
AU  - Tomizawa,Daisuke
AU  - Tanaka,Shiro
AU  - Iwamoto,Shotaro
AU  - Shimada,Akira
AU  - Saito,Akiko M
AU  - Yamashita,Yuka
AU  - Moritake,Hiroshi
AU  - Terui,Kiminori
AU  - Taga,Takashi
AU  - Matsuo,Hidemasa
AU  - Kosaka,Yoshiyuki
AU  - Koh,Katsuyoshi
AU  - Hosoi,Hajime
AU  - Kurosawa,Hidemitsu
AU  - Isoyama,Keiichi
AU  - Horibe,Keizo
AU  - Mizutani,Shuki
AU  - Adachi,Souichi
TI  - Fludarabine, cytarabine, granulocyte colony-stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia
SN  - 1442-200X
PY  - 2018///0503
KW  - Adolescent
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Child
KW  - Child, Preschool
KW  - Cytarabine
KW  - Drug Administration Schedule
KW  - Female
KW  - Granulocyte Colony-Stimulating Factor
KW  - Humans
KW  - Idarubicin
KW  - Lenograstim
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Male
KW  - Recombinant Proteins
KW  - Recurrence
KW  - Treatment Outcome
KW  - Vidarabine
KW  - analogs & derivatives
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1111/ped.13378
ER  -